Authors:
ABDELMEGUID SS
METCALF BW
CARR TJ
DEMARSH P
DESJARLAIS RL
FISHER S
GREEN DW
IVANOFF L
LAMBERT DM
MURTHY KHM
PETTEWAY SR
PITTS WJ
TOMASZEK TA
WINBORNE E
ZHAO BG
DREYER GB
MEEK TD
Citation: Ss. Abdelmeguid et al., AN ORALLY BIOAVAILABLE HIV-1 PROTEASE INHIBITOR CONTAINING AN IMIDAZOLE-DERIVED PEPTIDE-BOND REPLACEMENT - CRYSTALLOGRAPHIC AND PHARMACOKINETIC ANALYSIS, Biochemistry, 33(39), 1994, pp. 11671-11677
Authors:
IVANOFF L
GUTSHALL L
STERNBERG E
MORRIS J
HUNTER E
MATTHEWS TJ
PETTEWAY SR
Citation: L. Ivanoff et al., LETHAL MUTATION IN THE V3 LOOP OF HIV-1 GP120 IS(1)OVERCOME BY REVERSION IN TISSUE-CULTURE, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 710-710
Authors:
HARVIMA IT
HARVIMA RJ
NILSSON G
IVANOFF L
SCHWARTZ LB
Citation: It. Harvima et al., SEPARATION AND PARTIAL CHARACTERIZATION OF PROTEINASES WITH SUBSTRATE-SPECIFICITY FOR BASIC-AMINO-ACIDS FROM HUMAN MOLT-4 T-LYMPHOCYTES - IDENTIFICATION OF THOSE INHIBITED BY VARIABLE-LOOP-V3 PEPTIDES OF HIV-1(HUMAN IMMUNODEFICIENCY VIRUS-1) ENVELOPE GLYCOPROTEIN, Biochemical journal, 292, 1993, pp. 711-718